Search Results - "Xhyliu, Fjorela"

Chirality-pure carbon nanotubes show distinct complexation with recognition DNA sequences by Xhyliu, Fjorela, Ao, Geyou

“…Pure-chirality single-wall carbon nanotubes (SWCNTs) that are non-covalently complexed with recognition DNA sequences exhibit unique interaction behavior and…”
Get full text

Surface Coating- and Light-Controlled Oxygen Doping of Carbon Nanotubes by Xhyliu, Fjorela, Ao, Geyou

“…Tuning the optical properties of single-wall carbon nanotubes (SWCNTs) via oxygen doping has been a simple and effective approach to create fluorescent quantum…”
Get full text

Targeting of CD38 by the Tumor Suppressor miR-26a Serves as a Novel Potential Therapeutic Agent in Multiple Myeloma by Hu, Yi, Liu, Huimin, Fang, Chuanfeng, Li, Chen, Xhyliu, Fjorela, Dysert, Hayley, Bodo, Juraj, Habermehl, Gabriel, Russell, Benjamin E, Li, Wenjun, Chappell, Marcia, Jiang, Xiaofeng, Ondrejka, Sarah L, Hsi, Eric D, Maciejewski, Jaroslaw P, Yi, Qing, Anderson, Kenneth C, Munshi, Nikhil C, Ao, Geyou, Valent, Jason N, Lin, Jianhong, Zhao, Jianjun

“…Multiple myeloma is an incurable refractory hematologic malignancy arising from plasma cells in the bone marrow. Here we investigated miR-26a function in…”
Get full text

miR-26a as a novel potential therapeutic via inhibit CD38 translation and may overcome datatumumab resistance in multiple myeloma(MM) by Zhao, Jianjun, Hu, Yi, Liu, Huimin, Fang, Chuanfeng, Li, Chen, Xhyliu, Fjorela, Bodo, Juraj, Dysert, Hayley, Habermehl, Gabriel, Russell, Benjamin, Li, Wenjun, Chappell, Marcia, Jiang, Xiaofeng, Ondrejka, Sarah, Hsi, Eric, Maciejewski, Jaroslaw P, Yi, Qing, Anderson, Kenneth C, Munshi, Nikhil C, Ao, Geyou, Valent, Jason, Lin, Jianhong

“…Abstract Daratumumab is the first CD38 antibody drug for MM patients therapy. CD38 remains at a low level during daratumumab treatment and shows a sustained…”
Get full text